Cargando…
Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells
Glioblastoma (GBM) remains one of the most fatal human malignancies due to its high angiogenic and infiltrative capacities. Even with optimal therapy including surgery, radiotherapy and temozolomide, it is essentially incurable. GBM is among the most neovascularised neoplasms and its malignant progr...
Autores principales: | Momeny, Majid, Moghaddaskho, Farima, Gortany, Narges K., Yousefi, Hassan, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Mirshahvaladi, Shahab, Eyvani, Haniyeh, Barghi, Farinaz, Ahmadinia, Leila, Ghazi-Khansari, Mahmoud, Dehpour, Ahmad R., Amanpour, Saeid, Tavangar, Seyyed M., Dardaei, Leila, Emami, Amir H., Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347040/ https://www.ncbi.nlm.nih.gov/pubmed/28287096 http://dx.doi.org/10.1038/srep44075 |
Ejemplares similares
-
Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells
por: Momeny, Majid, et al.
Publicado: (2017) -
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells
por: Momeny, Majid, et al.
Publicado: (2017) -
Cardioprotective effects of sodium thiosulfate against doxorubicin-induced cardiotoxicity in male rats
por: Shekari, Maryam, et al.
Publicado: (2022) -
Tivozanib in the treatment of renal cell carcinoma
por: Hepgur, Mehmet, et al.
Publicado: (2013) -
Milestones for development of tivozanib for kidney cancer therapy
por: Crescentini, Robert, et al.
Publicado: (2012)